During the past decade, Hospital Raja Permaisuri Bainun conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 13 clinical trials were completed, i.e. on average, 40.6% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 10 clinical trials were completed. i.e. 45.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Raja Permaisuri Bainun" #1 sponsor was "Janssen Research & Development, LLC" with 7 trials, followed by "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 3 trials sponsored, "The George Institute" with 3 trials sponsored, "Celgene" with 2 trials sponsored and "Clinical Research Centre, Malaysia" with 2 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Raja Permaisuri Bainun" #1 collaborator was "Hospital Queen Elizabeth, Malaysia" with 3 trials as a collaborator, "Kuala Lumpur General Hospital" with 3 trials as a collaborator, "Hospital Enche Besar Hajjah Khalsom, Kluang, Johor" with 2 trials as a collaborator, "Hospital Melaka, Melaka" with 2 trials as a collaborator and "Hospital Raja Perempuan Zainab II, Kota Bahru, Kelantan" with 2 trials as a collaborator. Other collaborators include 27 different institutions and companies that were collaborators in the rest 29 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Raja Permaisuri Bainun" are "Arthritis, Psoriatic" (4 trials), "COVID-19" (4 trials), "Depressive Disorder, Major" (4 trials), "Rheumatoid Arthritis" (3 trials) and "Anosmia" (2 trials). Many other conditions were trialed in "Hospital Raja Permaisuri Bainun" in a lesser frequency.

Most popular intervention types in "Hospital Raja Permaisuri Bainun" are "Drug" (29 trials), "Other" (6 trials), "Biological" (3 trials), "Diagnostic Test" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Guselkumab" (5 trials), "Luspatercept" (2 trials), "Patient-Reported Online Questionnaire on Olfactory & Taste Disturbances" (2 trials) and "SSRI/SNRI" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Raja Permaisuri Bainun" are 36 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital Raja Permaisuri Bainun". undefined are not yet recruiting, 11 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Hospital Raja Permaisuri Bainun, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Raja Permaisuri Bainun, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 3 trials that are defined as “Not Applicable".